Question: CASE STUDY PROGRESS… The Provider Suspects Martin Is Experiencing Acute Rejection And Orders A Renal Biopsy, Which Confirms A Diagnosis Of Acute Rejection Of The Transplanted Kidney. 11) Describe The Timeframe For Acute Rejection And Briefly Explain The Pathophysiology Of Acute Rejection 12) What Are The Collaborative Care Options To Save The Kidney …

CASE STUDY PROGRESS… The provider suspects Martin is experiencing acute rejection and orders a renal biopsy, which confirms a diagnosis of acute rejection of the transplanted kidney. 11) Describe the timeframe for acute rejection and briefly explain the pathophysiology of acute rejection 12) What are the collaborative care options to save the kidney when rejection is present? 13) The healthcare provider adds mycophenolate (CellCept) 1 gram P.O. BID to Martin’s immunosuppressive regimen. How will mycophenolate help protect Martin’s kidney? 14) Glipizide is prescribed for Martin’s hyperglycemia. Martin asks if this means he is now diabetic. How would you answer him? 15) Martin asks you if this means he is going to lose the kidney and go back on dialysis. How would you respond? 16) How can you best support Martin and his family during this time? CASE STUDY OJITCOME… Martin does not experience any further episodes of acute rejection and within 6 months is able to be on lower doses of immunosuppressive therapy. With the lower level of immunosuppression, his elevated glucose resolves, and he does not develop diabetes: His kidney continues to function well, and he says that despite a few challenges that come with being a post-transplant patient, “I feel better than I have in years.”